Jay Octeau

Company: Capsida

Job title: Senior scientist

Seminars:

Innovating Next Generation BBB-Penetrant AAVs for Gene Therapy 11:00 am

Discussing innovative advancements in IV administered AAV capsids to access the CNS Using engineered AAVs to treat neurodegenerative disorders and beyondRead more

day: Conference Day One

Revolutionizing AAV Delivery Platforms: Minimizing Immunogenicity & Maximizing Biodistribution for Enhanced Brain Targeting 2:05 pm

Despite notable promising efforts to achieve brain-wide transduction in mice and monkeys, developing a BBB-crossing capsid remains an unsolved problem. • How can we translate successful cases of AAV delivery in vivo into clinical programs and overcome challenges of cross species differences in capsid property requirements? • Which features of capsid design should be improved…Read more

day: Pre-Conference 1 Track PM